Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Way of watching movies might be changing forever, Barron's says » 10:19
08/08/20
08/08
10:19
08/08/20
10:19
DIS

Disney

$129.92 /

-0.91 (-0.70%)

"Mulan" is…

"Mulan" is coming to Disney+ and how we watch movies might be changing forever, Ben Levisohn writes in this week's edition of Barron's. Disney's decision to bring the movie to its subscription service shouldn't come as surprise with few signs that Americans were ready to return to movie theaters, but "Mulan" is no "Artemis Fowl," which was added to Disney+ free to subscribers, with the live-action remake of its 1998 animated feature costing an additional $29.99 to watch, the author notes. If Disney's digital strategy is good for its stock, as investors seem to feel comfortable with where Disney is headed, it most certainly not for the shares of traditional movie theaters, the publication adds. Reference Link

ShowHide Related Items >><<
DIS Disney
$129.92 /

-0.91 (-0.70%)

DIS Disney
$129.92 /

-0.91 (-0.70%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
DIS Disney
$129.92 /

-0.91 (-0.70%)

DIS Disney
$129.92 /

-0.91 (-0.70%)

DIS Disney
$129.92 /

-0.91 (-0.70%)

DIS Disney
$129.92 /

-0.91 (-0.70%)

Friday
Periodicals
WarnerMedia CEO shakes up entertainment management, Deadline says » 16:32
08/07/20
08/07
16:32
08/07/20
16:32
T

AT&T

$30.03 /

+0.165 (+0.55%)

WarnerMedia CEO Jason…

WarnerMedia CEO Jason Kilar is engaging a major overhaul of the AT&T unit's management, with Warner Bros. chief Ann Sarnoff assuming oversight of all network, film, and TV studio and streaming assets, Deadline's Nellie Andreeva reports. Bob Greenblatt, Chairman, WarnerMedia Entertainment and Direct-to-Consumer, Kevin Reilly, Chief Content Officer, HBO Max and president, TNT, TBS, and truTV, as well as Keith Cocozza, EVP of Corporate Marketing and Communications, will all be leaving the company, Andreeva notes. In addition, HBO's Casey Bloys will receive expanded responsibilities, including oversight of digital content for HBO Max and the domestic linear networks TNT, TBS, and TruTV, the author says. Reference Link

ShowHide Related Items >><<
T AT&T
$30.03 /

+0.165 (+0.55%)

T AT&T
$30.03 /

+0.165 (+0.55%)

07/24/20 RBC Capital
AT&T price target lowered to $32 from $38 at RBC Capital
07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
06/25/20 BTIG
RingCentral price target raised to $325 from $275 at BTIG
06/15/20 Stephens
Electronic Arts seems like best fit as buyer for WB Interactive, says Stephens
T AT&T
$30.03 /

+0.165 (+0.55%)

T AT&T
$30.03 /

+0.165 (+0.55%)

T AT&T
$30.03 /

+0.165 (+0.55%)

T AT&T
$30.03 /

+0.165 (+0.55%)

Periodicals
Judge ends rule preventing studios from owning theaters, CNBC reports » 14:57
08/07/20
08/07
14:57
08/07/20
14:57
AMC

AMC Entertainment

$4.92 /

+0.8 (+19.42%)

, CNK

Cinemark

$11.04 /

+0.54 (+5.14%)

, IMAX

IMAX

$11.79 /

+0.3 (+2.61%)

, RGC

Regal Entertainment

$23.00 /

+ (+0.00%)

, DIS

Disney

$129.25 /

-1.58 (-1.21%)

, T

AT&T

$29.95 /

+0.09 (+0.30%)

, SNE

Sony

$79.38 /

-1.125 (-1.40%)

, CMCSA

Comcast

$42.62 /

-0.25 (-0.58%)

, VIAC

ViacomCBS

$25.81 /

-1.07 (-3.98%)

, LGF.A

Lionsgate

$7.97 /

+0.2 (+2.57%)

U.S. District Judge…

U.S. District Judge Analisa Torres in Manhattan granted the U.S. government's request to immediately end the Paramount Decrees, a set of decades-old antitrust rules that ended Hollywood's monopoly on producing, distributing and exhibiting movies, reported CNBC. The Justice Department has argued, successfully, that the decrees were no longer needed after multiplexes, broadcast and cable TV, DVDs and the internet changed how people watch movies, the report noted. Publicly traded companies in film exhibition include AMC Entertainment (AMC), Cinemark (CNK), IMAX (IMAX) and Regal Entertainment (RGC). Publicly traded film studio owners include AT&T (T), Comcast (CMCSA), Disney (DIS), Lionsgate (LGF.A), Sony (SNE) and ViacomCBS (VIAC). Reference Link

ShowHide Related Items >><<
VIAC ViacomCBS
$25.81 /

-1.07 (-3.98%)

T AT&T
$29.95 /

+0.09 (+0.30%)

SNE Sony
$79.38 /

-1.125 (-1.40%)

RGC Regal Entertainment
$23.00 /

+ (+0.00%)

LGF.A Lionsgate
$7.97 /

+0.2 (+2.57%)

IMAX IMAX
$11.79 /

+0.3 (+2.61%)

DIS Disney
$129.25 /

-1.58 (-1.21%)

CNK Cinemark
$11.04 /

+0.54 (+5.14%)

CMCSA Comcast
$42.62 /

-0.25 (-0.58%)

AMC AMC Entertainment
$4.92 /

+0.8 (+19.42%)

AMC AMC Entertainment
$4.92 /

+0.8 (+19.42%)

07/13/20 MKM Partners
MKM Partners lowers price targets in Cinema sector
06/30/20 Imperial Capital
AMC Entertainment price target lowered to $4 from $6 at Imperial Capital
06/29/20 Credit Suisse
Cinemark downgraded to Neutral from Outperform at Credit Suisse
06/29/20 Credit Suisse
AMC Entertainment downgraded to Underperform from Neutral at Credit Suisse
CNK Cinemark
$11.04 /

+0.54 (+5.14%)

08/05/20 JPMorgan
Cinemark price target lowered to $19 from $23 at JPMorgan
07/29/20 Wedbush
Cinemark price target lowered to $15 from $20 at Wedbush
07/15/20 Goldman Sachs
Cinemark initiated with a Neutral at Goldman Sachs
IMAX IMAX
$11.79 /

+0.3 (+2.61%)

07/29/20 Canaccord
IMAX price target lowered to $14.50 from $16 at Canaccord
07/15/20 Goldman Sachs
Imax initiated with a Buy at Goldman Sachs
04/28/20
Fly Intel: Top five analyst upgrades
RGC Regal Entertainment
$23.00 /

+ (+0.00%)

03/18/20 Benchmark
Benchmark cuts National CineMedia to Hold as Universal goes to home with Trolls
DIS Disney
$129.25 /

-1.58 (-1.21%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
T AT&T
$29.95 /

+0.09 (+0.30%)

07/24/20 RBC Capital
AT&T price target lowered to $32 from $38 at RBC Capital
07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
06/25/20 BTIG
RingCentral price target raised to $325 from $275 at BTIG
06/15/20 Stephens
Electronic Arts seems like best fit as buyer for WB Interactive, says Stephens
SNE Sony
$79.38 /

-1.125 (-1.40%)

08/05/20 Oppenheimer
Sony price target raised to $100 from $70 at Oppenheimer
07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
CMCSA Comcast
$42.62 /

-0.25 (-0.58%)

08/03/20 Deutsche Bank
Comcast price target raised to $53 from $47 at Deutsche Bank
08/03/20 UBS
Charter price target raised to $650 from $575 at UBS
07/01/20
Fly Intel: Top five analyst upgrades
07/01/20 Bernstein
Comcast upgraded to Outperform from Market Perform at Bernstein
VIAC ViacomCBS
$25.81 /

-1.07 (-3.98%)

08/07/20 RBC Capital
ViacomCBS price target raised to $26 from $17 at RBC Capital
08/07/20 Benchmark
ViacomCBS price target raised to $35 from $24 at Benchmark
07/13/20
Fly Intel: Top five analyst initiations
07/13/20
Fly Intel: Top five analyst downgrades
LGF.A Lionsgate
$7.97 /

+0.2 (+2.57%)

07/13/20 Goldman Sachs
Lionsgate initiated with a Neutral at Goldman Sachs
06/18/20 Cowen
Lionsgate remain underappreciated OTT play, says Cowen
04/27/20 RBC Capital
Lionsgate initiated with a Sector Perform at RBC Capital
04/22/20 Deutsche Bank
Lionsgate price target lowered to $10 from $22 at Deutsche Bank
VIAC ViacomCBS
$25.81 /

-1.07 (-3.98%)

T AT&T
$29.95 /

+0.09 (+0.30%)

SNE Sony
$79.38 /

-1.125 (-1.40%)

LGF.A Lionsgate
$7.97 /

+0.2 (+2.57%)

IMAX IMAX
$11.79 /

+0.3 (+2.61%)

DIS Disney
$129.25 /

-1.58 (-1.21%)

CNK Cinemark
$11.04 /

+0.54 (+5.14%)

CMCSA Comcast
$42.62 /

-0.25 (-0.58%)

AMC AMC Entertainment
$4.92 /

+0.8 (+19.42%)

VIAC ViacomCBS
$25.81 /

-1.07 (-3.98%)

T AT&T
$29.95 /

+0.09 (+0.30%)

SNE Sony
$79.38 /

-1.125 (-1.40%)

LGF.A Lionsgate
$7.97 /

+0.2 (+2.57%)

IMAX IMAX
$11.79 /

+0.3 (+2.61%)

DIS Disney
$129.25 /

-1.58 (-1.21%)

CNK Cinemark
$11.04 /

+0.54 (+5.14%)

CMCSA Comcast
$42.62 /

-0.25 (-0.58%)

AMC AMC Entertainment
$4.92 /

+0.8 (+19.42%)

VIAC ViacomCBS
$25.81 /

-1.07 (-3.98%)

T AT&T
$29.95 /

+0.09 (+0.30%)

SNE Sony
$79.38 /

-1.125 (-1.40%)

RGC Regal Entertainment
$23.00 /

+ (+0.00%)

LGF.A Lionsgate
$7.97 /

+0.2 (+2.57%)

IMAX IMAX
$11.79 /

+0.3 (+2.61%)

DIS Disney
$129.25 /

-1.58 (-1.21%)

CNK Cinemark
$11.04 /

+0.54 (+5.14%)

CMCSA Comcast
$42.62 /

-0.25 (-0.58%)

AMC AMC Entertainment
$4.92 /

+0.8 (+19.42%)

VIAC ViacomCBS
$25.81 /

-1.07 (-3.98%)

T AT&T
$29.95 /

+0.09 (+0.30%)

SNE Sony
$79.38 /

-1.125 (-1.40%)

DIS Disney
$129.25 /

-1.58 (-1.21%)

CNK Cinemark
$11.04 /

+0.54 (+5.14%)

CMCSA Comcast
$42.62 /

-0.25 (-0.58%)

AMC AMC Entertainment
$4.92 /

+0.8 (+19.42%)

Options
Salesforce call volume above normal and directionally bullish » 13:45
08/07/20
08/07
13:45
08/07/20
13:45
CRM

Salesforce

$200.43 /

-7.35 (-3.54%)

Bullish option flow…

Bullish option flow detected in Salesforce with 35,536 calls trading, 2x expected, and implied vol increasing almost 2 points to 39.15%. Jan-21 230 calls and Jul-21 230 calls are the most active options, with total volume in those strikes near 13,100 contracts. The Put/Call Ratio is 0.31. Earnings are expected on August 25th.

ShowHide Related Items >><<
CRM Salesforce
$200.43 /

-7.35 (-3.54%)

CRM Salesforce
$200.43 /

-7.35 (-3.54%)

07/27/20 Morgan Stanley
Morgan Stanley downgrades Software industry view to In-Line from Attractive
07/14/20 Piper Sandler
Salesforce price target raised to $210 from $193 at Piper Sandler
06/24/20 Goldman Sachs
Salesforce price target raised to $220 from $204 at Goldman Sachs
06/22/20 Jefferies
Salesforce price target raised to $220 from $205 at Jefferies
CRM Salesforce
$200.43 /

-7.35 (-3.54%)

CRM Salesforce
$200.43 /

-7.35 (-3.54%)

CRM Salesforce
$200.43 /

-7.35 (-3.54%)

CRM Salesforce
$200.43 /

-7.35 (-3.54%)

Thursday
Recommendations
Intuit partnership reinforces Bill.com long-term opportunity, says Piper Sandler » 13:28
08/06/20
08/06
13:28
08/06/20
13:28
BILL

Bill.com

$100.22 /

-0.8 (-0.79%)

, INTU

Intuit

$310.47 /

-0.52 (-0.17%)

Piper Sandler analyst…

Piper Sandler analyst Brent Bracelin notes that Bill.com (BILL) and Intuit (INTU) jointly discussed on Thursday extending the partnership to include the Bill.com platform as part of the new mid-market initiative for the QuickBooks Online Advanced where invoice volumes could be much higher than the traditional Intuit micro-SMB customer base. While the Intuit partnership might not have a material impact near-term, Bracelin views this deal as reinforcing the longer-term opportunity for Bill.com to help digitize the back-office for small businesses via unique bank, accounting, and technology partnerships. He has an Overweight rating and a price target of $85 on Bill.com's shares.

ShowHide Related Items >><<
INTU Intuit
$310.47 /

-0.52 (-0.17%)

BILL Bill.com
$100.22 /

-0.8 (-0.79%)

BILL Bill.com
$100.22 /

-0.8 (-0.79%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Oppenheimer
Bill.com initiated with an Outperform at Oppenheimer
06/29/20 Goldman Sachs
Bill.com price target raised to $90 from $60 at Goldman Sachs
05/28/20
Fly Intel: Top five analyst upgrades
INTU Intuit
$310.47 /

-0.52 (-0.17%)

06/22/20 Jefferies
Intuit staff cuts not indicative of weak demand, says Jefferies
05/22/20 RBC Capital
Intuit price target raised to $315 from $280 at RBC Capital
05/22/20 Guggenheim
Guggenheim ups Intuit price target to $320 with odds of worst case diminishing
05/22/20 Citi
Intuit price target raised to $292 from $272 at Citi
INTU Intuit
$310.47 /

-0.52 (-0.17%)

BILL Bill.com
$100.22 /

-0.8 (-0.79%)

  • 11
    Jun
  • 12
    Dec
INTU Intuit
$310.47 /

-0.52 (-0.17%)

INTU Intuit
$310.47 /

-0.52 (-0.17%)

BILL Bill.com
$100.22 /

-0.8 (-0.79%)

BILL Bill.com
$100.22 /

-0.8 (-0.79%)

Periodicals
Third Point took new long position in Disney, CNBC reports » 12:02
08/06/20
08/06
12:02
08/06/20
12:02
DIS

Disney

$127.55 /

-0.085 (-0.07%)

Dan Loeb has confirmed in…

Dan Loeb has confirmed in comments to CNBC and in his firm's letter to investors that the firm has taken a new long position in Disney, CNBC's Scott Wapner said in an on-air report.

ShowHide Related Items >><<
DIS Disney
$127.55 /

-0.085 (-0.07%)

DIS Disney
$127.55 /

-0.085 (-0.07%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
DIS Disney
$127.55 /

-0.085 (-0.07%)

DIS Disney
$127.55 /

-0.085 (-0.07%)

DIS Disney
$127.55 /

-0.085 (-0.07%)

DIS Disney
$127.55 /

-0.085 (-0.07%)

Periodicals
Hedge fund Third Point took positions in Alibaba, JD.com, Reuters reports » 11:22
08/06/20
08/06
11:22
08/06/20
11:22
BABA

Alibaba

$260.09 /

-4.89 (-1.85%)

, JD

JD.com

$64.18 /

-1.345 (-2.05%)

, DIS

Disney

$128.11 /

+0.475 (+0.37%)

The hedge fund took a new…

The hedge fund took a new long position in Disney (DIS) in Q2, according to the firm's shareholder letter, cited by Reuters.

ShowHide Related Items >><<
JD JD.com
$64.18 /

-1.345 (-2.05%)

DIS Disney
$128.11 /

+0.475 (+0.37%)

BABA Alibaba
$260.09 /

-4.89 (-1.85%)

BABA Alibaba
$260.09 /

-4.89 (-1.85%)

07/31/20 Stifel
Stifel downgrades Alphabet to Hold, prefers other mega cap tech stocks
07/20/20
Alibaba initiated with a Buy at CMB International
07/17/20 Baird
Alibaba price target raised to $275 from $230 at Baird
07/17/20 Stifel
Alibaba price target raised to $270 from $230 at Stifel
JD JD.com
$64.18 /

-1.345 (-2.05%)

07/17/20 Stifel
JD.com price target raised to $60 from $50 at Stifel
06/30/20 Mizuho
JD.com price target raised to $75 from $62 at Mizuho
06/19/20 Barclays
JD.com price target raised to $65 from $59 at Barclays
06/19/20 Morgan Stanley
6.18 promotion in China released pent-up buying demand, says Morgan Stanley
DIS Disney
$128.11 /

+0.475 (+0.37%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
JD JD.com
$64.18 /

-1.345 (-2.05%)

DIS Disney
$128.11 /

+0.475 (+0.37%)

BABA Alibaba
$260.09 /

-4.89 (-1.85%)

JD JD.com
$64.18 /

-1.345 (-2.05%)

DIS Disney
$128.11 /

+0.475 (+0.37%)

BABA Alibaba
$260.09 /

-4.89 (-1.85%)

JD JD.com
$64.18 /

-1.345 (-2.05%)

DIS Disney
$128.11 /

+0.475 (+0.37%)

BABA Alibaba
$260.09 /

-4.89 (-1.85%)

JD JD.com
$64.18 /

-1.345 (-2.05%)

DIS Disney
$128.11 /

+0.475 (+0.37%)

BABA Alibaba
$260.09 /

-4.89 (-1.85%)

Hot Stocks
Bill.com extends partnership with Intuit to integrate services into QuickBooks » 09:07
08/06/20
08/06
09:07
08/06/20
09:07
BILL

Bill.com

$101.02 /

+6.31 (+6.66%)

, INTU

Intuit

$310.99 /

+0.55 (+0.18%)

Bill.com (BILL) has…

Bill.com (BILL) has extended its partnership with Intuit (INTU). The enhanced partnership will add advanced bill payment and workflow automation capabilities for QuickBooks Online Advanced customers as part of Intuit's application ecosystem, in addition to continued support for the Simple Bill Pay service in QuickBooks Online. As more mid-sized businesses shift to cloud-based financial solutions that offer ease-of-use and affordability, these customers also need a richer set of features to keep pace with the complexities of their business. QuickBooks Online Advanced, or QBOAV, is designed for growing mid-sized businesses who need a robust, customizable solution. Bill.com's accounts payable solutions, combined with QBOAV meet these mid-sized businesses on their growth journey. According to Intuit, there are an estimated 1.5M mid-sized businesses in the United States that can benefit from the combined solution's enhanced control over cash flow, streamlined payments and associated workflows.

ShowHide Related Items >><<
INTU Intuit
$310.99 /

+0.55 (+0.18%)

BILL Bill.com
$101.02 /

+6.31 (+6.66%)

BILL Bill.com
$101.02 /

+6.31 (+6.66%)

07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Oppenheimer
Bill.com initiated with an Outperform at Oppenheimer
06/29/20 Goldman Sachs
Bill.com price target raised to $90 from $60 at Goldman Sachs
05/28/20
Fly Intel: Top five analyst upgrades
INTU Intuit
$310.99 /

+0.55 (+0.18%)

06/22/20 Jefferies
Intuit staff cuts not indicative of weak demand, says Jefferies
05/22/20 RBC Capital
Intuit price target raised to $315 from $280 at RBC Capital
05/22/20 Guggenheim
Guggenheim ups Intuit price target to $320 with odds of worst case diminishing
05/22/20 Citi
Intuit price target raised to $292 from $272 at Citi
INTU Intuit
$310.99 /

+0.55 (+0.18%)

BILL Bill.com
$101.02 /

+6.31 (+6.66%)

  • 11
    Jun
  • 12
    Dec
INTU Intuit
$310.99 /

+0.55 (+0.18%)

INTU Intuit
$310.99 /

+0.55 (+0.18%)

BILL Bill.com
$101.02 /

+6.31 (+6.66%)

BILL Bill.com
$101.02 /

+6.31 (+6.66%)

Hot Stocks
Intuit agrees to buy Singapore inventory software maker TradeGecko » 05:58
08/06/20
08/06
05:58
08/06/20
05:58
INTU

Intuit

$310.99 /

+0.55 (+0.18%)

Intuit announced this…

Intuit announced this week that it has entered into an agreement to acquire TradeGecko, the inventory and order management platform "that makes omni-channel commerce easy for small businesses. Integrating QuickBooks' suite of financial, payment, reporting and accounting tools with TradeGecko's robust inventory and order management system will help product sellers run and grow their business, all on one powerful platform. The transaction is expected to close in September 2020." Reference Link

ShowHide Related Items >><<
INTU Intuit
$310.99 /

+0.55 (+0.18%)

INTU Intuit
$310.99 /

+0.55 (+0.18%)

06/22/20 Jefferies
Intuit staff cuts not indicative of weak demand, says Jefferies
05/22/20 RBC Capital
Intuit price target raised to $315 from $280 at RBC Capital
05/22/20 Guggenheim
Guggenheim ups Intuit price target to $320 with odds of worst case diminishing
05/22/20 Citi
Intuit price target raised to $292 from $272 at Citi
INTU Intuit
$310.99 /

+0.55 (+0.18%)

INTU Intuit
$310.99 /

+0.55 (+0.18%)

INTU Intuit
$310.99 /

+0.55 (+0.18%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 17:41
08/05/20
08/05
17:41
08/05/20
17:41
DIS

Disney

$127.64 /

+10.185 (+8.67%)

, CVS

CVS Health

$64.44 /

-0.55 (-0.85%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

, JNJ

Johnson & Johnson

$148.39 /

+1.19 (+0.81%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

, BNTX

BioNTech

$81.28 /

-1.89 (-2.27%)

, MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, TDOC

Teladoc

$202.21 /

-46.9 (-18.83%)

, LVGO

Livongo Health

$128.16 /

-16.32 (-11.30%)

, XOM

Exxon Mobil

$43.84 /

+0.36 (+0.83%)

, CI

Cigna

$175.07 /

+1.53 (+0.88%)

, FLGT

Fulgent Genetics

$35.97 /

+6.29 (+21.19%)

, ENLC

EnLink Midstream

$2.99 /

+0.455 (+17.95%)

, LPSN

LivePerson

$56.16 /

+9.91 (+21.43%)

, AIZ

Assurant

$122.40 /

+15.32 (+14.31%)

, EVER

EverQuote

$41.61 /

-12.64 (-23.30%)

, VAPO

Vapotherm

$32.87 /

-20.59 (-38.51%)

, NEWR

New Relic

$55.85 /

-17.655 (-24.02%)

, CDLX

Cardlytics

$66.08 /

-6.6 (-9.08%)

The S&P had its fourth…

Open Full Text

ShowHide Related Items >><<
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

EVER EverQuote
$41.61 /

-12.64 (-23.30%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

AIZ Assurant
$122.40 /

+15.32 (+14.31%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
CVS CVS Health
$64.44 /

-0.55 (-0.85%)

08/06/20 Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/06/20 H.C. Wainwright
Novavax price target raised to $290 from $132 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

07/21/20
Fly Intel: Top five analyst upgrades
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

08/06/20 Deutsche Bank
Teladoc price target lowered to $225 from $238 at Deutsche Bank
08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
08/06/20 Truist
Teladoc upgraded to Buy from Hold at Truist
LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

08/06/20 Needham
Livongo Health downgraded to Hold from Buy at Needham
08/05/20 Stifel
Stifel views Teledoc, Livongo as largely complementary businesses
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

07/23/20 Truist
SunTrust starts Exxon with Hold rating, $41 price target
07/23/20 Truist
Exxon Mobil initiated with a Hold at SunTrust
06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
CI Cigna
$175.07 /

+1.53 (+0.88%)

08/06/20 RBC Capital
Ontrak price target raised to $50 from $35 at RBC Capital
07/01/20 SVB Leerink
Cigna reinstated with a Market Perform at SVB Leerink
06/29/20 SVB Leerink
Inspire Medical price target raised to $110 from $85 at SVB Leerink
06/05/20 BMO Capital
Cigna price target raised to $242 from $215 at BMO Capital
FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

08/05/20 Piper Sandler
Fulgent Genetics price target raised to $68 from $31 at Piper Sandler
07/27/20 Piper Sandler
Fulgent Genetics price target raised to $31 from $21 at Piper Sandler
06/17/20 Piper Sandler
Fulgent Genetics price target raised to $21 from $18 at Piper Sandler
05/29/20 BTIG
Fulgent Genetics initiated with a Buy at BTIG
ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

05/06/20 Mizuho
EnLink Midstream price target lowered to $2.50 from $7 at Mizuho
04/02/20 Credit Suisse
EnLink Midstream downgraded to Underperform from Neutral at Credit Suisse
03/24/20 Barclays
EnLink Midstream downgraded to Underweight from Equal Weight at Barclays
03/12/20 Raymond James
EnLink Midstream downgraded to Market Perform from Outperform at Raymond James
LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

08/05/20 B. Riley FBR
LivePerson price target raised to $63 from $49 at B. Riley FBR
08/05/20 Barclays
LivePerson price target raised to $64 from $49 at Barclays
08/05/20 Craig-Hallum
LivePerson price target raised to $60 from $34 at Craig-Hallum
08/05/20 Roth Capital
LivePerson price target raised to $75 from $53 at Roth Capital
AIZ Assurant
$122.40 /

+15.32 (+14.31%)

10/03/19 Truist
Assurant price target raised to $145 from $140 at SunTrust
EVER EverQuote
$41.61 /

-12.64 (-23.30%)

07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
06/02/20 Oppenheimer
EverQuote price target raised to $65 from $50 at Oppenheimer
05/27/20 Canaccord
EverQuote price target raised to $60 from $50 at Canaccord
VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
NEWR New Relic
$55.85 /

-17.655 (-24.02%)

08/05/20 UBS
New Relic sales turnaround taking longer than expected, says UBS
08/05/20 JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
08/05/20 JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
08/04/20 BMO Capital
New Relic price target raised to $78 from $70 at BMO Capital
CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

08/05/20 Craig-Hallum
Cardlytics price target raised to $70 from $50 at Craig-Hallum
07/09/20 Truist
Cardlytics price target raised to $75 from $55 at SunTrust
05/12/20 Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
05/12/20 Truist
Cardlytics price target raised to $55 from $50 at SunTrust
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

EVER EverQuote
$41.61 /

-12.64 (-23.30%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

AIZ Assurant
$122.40 /

+15.32 (+14.31%)

  • 23
    Jul
  • 19
    May
  • 07
    May
  • 12
    Feb
  • 06
    Feb
  • 12
    Dec
  • 14
    Nov
  • 10
    Oct
  • 11
    Sep
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.